Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Taisho Pharmaceutical
Asia
Fujifilm, WuXi STA, Hanmi, BeiGene and more—Fierce Pharma Asia
Fufjilm and WuXi STA expand in the U.S. Hanmi's GLP-1 drug shows heart and kidney benefits. BeiGene is cleared for a $3 billion IPO in China.
Angus Liu
Jul 2, 2021 9:28am
Dr. Reddy's, Insilico-Taisho, Fosun's Gland—FiercePharmaAsia
Oct 23, 2020 10:10am
Takeda offloads $670M of European drugs
Apr 24, 2020 12:17pm
Bristol-Myers Squibb hands Upsa consumer biz to Taisho for $1.6B
Dec 19, 2018 9:57am
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa: report
Dec 17, 2018 11:43am
